Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Trump's Surgeon General Nominee Caught in GOP Crossfire over MAHA
President Trump’s nominee for surgeon general, health‑coach Casey Means, remains stalled in the Senate as key Republican senators refuse to back her. Means, an influencer with an expired medical license, faces criticism over her lack of public‑health experience and controversial vaccine comments. Trump briefly entertained withdrawing the nomination but quickly reaffirmed his support, highlighting the administration’s limited leverage. The impasse reflects growing GOP caution about the Make America Healthy Again agenda amid looming midterm elections.
Pharma Pulse: Foundayo’s FDA Approval and the Strategic Risk of Pharmacy Data Consolidation
Eli Lilly’s Foundayo became the first new molecular entity approved under the FDA’s National Priority Voucher pilot, clearing in a record 50 days. It is the only GLP‑1 weight‑loss pill that can be taken without food or water restrictions, aiming to...
Scientists Cured Type 1 Diabetes in Mice by Creating a Blended Immune System
Scientists have cured type 1 diabetes in mice by creating a blended, or chimeric, immune system that tolerates transplanted insulin‑producing cells without lifelong immunosuppression. The protocol combines donor bone‑marrow stem cells, islet cells, low‑dose radiation, antibodies and the drug baricitinib, allowing...
‘This Is an Overlooked Catastrophe’: Why Do so Many Hospitals Not Accept ...
A widening crisis is emerging as an increasing number of hospitals across the United States refuse to accept Medicare Advantage (MA) plans for oncology services. The trend is not limited to Florida; major academic and community hospitals nationwide are tightening...
What Will Approval of Foundayo GLP-1 Tablets Bring?
The FDA has approved Foundayo (orforglipron), the first non‑peptide oral GLP‑1 tablet for obesity. As a small‑molecule drug, it sidesteps the manufacturing complexities that plagued peptide injectables like semaglutide and tirzepatide. Daily oral dosing promises easier adherence compared with weekly...
Humanitarian Medicine Under Fire: Relief Organizations Serving Wounded Civilians in Gaza and Lebanon
The relentless bombing campaigns in Gaza and southern Lebanon since 2023 have devastated health infrastructure, leaving hospitals overwhelmed and civilian populations without basic medical care. International responders—Médecins Sans Frontières, the International Committee of the Red Cross and its Red Crescent...
Postbiotic Supplement May Protect Against Childhood Dental Caries: RCT
A randomized pilot study in Kraków gave 72 preschoolers chewable tablets containing 20 mg of heat‑inactivated Lactobacillus salivarius HM‑6 Paradens for two weeks. Children receiving the postbiotic showed a marked drop in Streptococcus mutans and a rise in beneficial Lactobacillus spp.,...
What the Research Actually Says About Home Modifications and Fall Prevention
Falls among adults 65+ are a leading cause of injury‑related hospitalization, with the majority occurring at home. Robust research, including a Cochrane review of 159 trials, shows that targeted home modifications—especially in bathrooms and stairways—significantly reduce fall incidence. Interventions are...
US Scientists Sequence 1,000 Genomes From Measles, a Disease Long Eliminated With Vaccines
The CDC has posted its first batch of whole‑genome sequences from roughly 1,000 measles viruses collected in 2025‑2026, marking the United States' inaugural use of large‑scale genomic surveillance for the disease. The data will allow researchers to trace transmission pathways...
APOE4 Variant Linked to Greater Neurological Damage in Multiple Sclerosis
A UK Biobank study of 188 multiple sclerosis patients reveals that carriers of the APOE4 gene variant experience significantly greater neurodegeneration than non‑carriers. APOE4 carriers showed higher blood levels of neurofilament light chain and glial fibrillary acidic protein, more extensive...
Actinogen Treats First Patient in XanaMIA Trial for Alzheimer’s
Actinogen Medical has begun treating the first participant in the open‑label extension (OLE) of its Phase IIb/III XanaMIA trial for Alzheimer’s disease. The OLE allows eligible U.S. and Australian subjects to receive Xanamem 10 mg daily for up to 25 months, collecting...
This Week in European MedTech and HealthTech: 2nd April 2026
European MedTech entered a phase of regulatory convergence and digital integration in the week of March 26‑April 2, 2026. BD launched its Pyxis™ Pro dispensing system and Incada™ Connected Care platform on the AWS European Sovereign Cloud, addressing EU data‑sovereignty rules. The European Commission...
Cogent Biosciences Reports US FDA’s NDA Submission of Bezuclastinib for Gastrointestinal Stromal Tumors (GIST)
Cogent Biosciences announced that the U.S. FDA has received a New Drug Application for bezuclastinib under the Real-Time Oncology Review program, targeting gastrointestinal stromal tumor patients who have progressed after imatinib. The Phase III PEAK trial, comparing bezuclastinib plus sunitinib to...
Recent Billing Code Changes Wreaking Havoc for Radiation Oncologists, New Survey Finds
On Jan. 1, 2026, the CPT Editorial Panel introduced three-tier radiation‑therapy billing codes, eliminating code 77014 and adding a professional‑component code. A survey of 160 ASTRO members shows more than two‑thirds experiencing payment drops of 10% or higher, with some cuts exceeding...
Annovis Publishes Historical Review of Buntanetap
Annovis released a historical review of its investigational drug Buntanetap in The Scientist, charting its evolution from a 19th‑century execution poison to a modern candidate for Alzheimer’s and Parkinson’s disease. The article details discovery, mechanism elucidation, chemical optimization, and progression...
Humanaut to Open Dallas Clinic, Launches Founding Membership Presale
Humanaut announced the opening of its first flagship clinic in Dallas, Texas, alongside a founding membership presale. The clinic will deliver metabolic profiling, continuous glucose monitoring, and AI‑driven health coaching under a $5,000 annual membership. The presale targets $10 million to...
New FDA‑approved Oral Weight‑loss Pill Expands Patient Options
So… hot off the press: a NEW weight loss PILL just got FDA approved. We’ve had oral (non-injectable) GLP-1s before — but this is one of the first specifically for weight management. When it reaches Malaysia, it could significantly increase demand...
How Acclaim Autism Cut Patient Onboarding From Six Months to Four Days with Appian
Acclaim Autism, a Philadelphia‑based autism‑care provider, used Appian’s low‑code automation to shrink patient onboarding from six months to four days. Insurance denial rates fell from 80% to 5%, and monthly intake rose from three to 47 patients, a fifteen‑fold increase....
Smarter Hiring Strategies for Modern Healthcare Practices
Healthcare practices are abandoning costly full‑time hiring models in favor of hybrid workforces that combine on‑site clinicians with remote administrative talent. Remote roles such as medical scribes and virtual receptionists are cutting documentation time by over two hours per day...
I-Lumen Receives FDA IDE to Start US I-SIGHT2 Enrollment
I‑Lumen announced that the U.S. Food and Drug Administration has granted an Investigational Device Exemption (IDE) for its i‑SIGHT2 clinical study. The clearance allows the company to begin enrolling participants in the United States to evaluate its breath‑based metabolic monitoring...
JenaValve Launches Trilogy Transcatheter Heart Valve System in the US to Treat Symptomatic, Severe Aortic Regurgitation (ssAR)
JenaValve has begun commercializing its Trilogy Transcatheter Heart Valve (THV) system in the United States, becoming the first FDA‑approved transcatheter device for symptomatic, severe aortic regurgitation (ssAR). The valve uses radiopaque locators that attach directly to native leaflets, enabling stable...
Live Not By Lies
Dr. McFillin’s post draws on Solzhenitsyn’s 1974 essay “Live Not By Lies” to argue that the modern mental‑health industry thrives on collective deception. He identifies two core falsehoods: that psychiatric disorders are brain diseases and that DSM diagnoses are medical...
Eli Lilly Reports US FDA Approval of Foundayo (Orforglipron) for Weight Loss
The U.S. FDA has approved Foundayo (orforglipron), Lilly’s first oral GLP‑1 pill, for obese or overweight adults with weight‑related health issues, to launch via LillyDirect on April 6, 2026. In the ATTAIN‑1 trial the highest dose produced an average 27.3‑lb (12.4%) weight...
All-Electric, All New: Inside UCI Health’s Ground-Up Hospital
UCI Health opened its new Irvine campus in December 2025, a seven‑story, 350,000 sq ft, 177‑bed acute care hospital built from the ground up as an all‑electric facility. The hospital features 22 operating rooms on a massive "surgery megafloor," advanced imaging, labs,...
Merit Medical Acquires View Point for $140M
Merit Medical Systems announced a $140 million acquisition of View Point Medical, adding the FDA‑cleared OneMark Detection Imaging System and tissue markers to its oncology portfolio. The deal includes $90 million upfront and $50 million in two anniversary installments. Merit expects the OneMark...
Samsung Medical Center Sets New Bar in Smart Hospital Transformation with AI-Ready Systems
Samsung Medical Center (SMC) in South Korea has re‑validated its IT infrastructure at Stage 7 of the HIMSS INFRAM model, confirming world‑class maturity across cybersecurity, adoption, sustainability, performance and outcomes. The hospital completed a massive data‑centre relocation with only 20 minutes of...
Korean Hospitals Outpace Global Peers in Digital Maturity: Pilot Study
South Korean hospitals scored an average of 285 out of 400 on the HIMSS Digital Health Indicator, well above the 2020 global average of 166 and the Asia‑Pacific average of 239. The pilot assessed ten leading institutions and highlighted strong...
French AI: 20 Million Funding for Generare to Find Better Data in Nature
Generare, a Paris‑based tech‑bio startup, raised €20 million in Series A funding to expand its proprietary library of evolution‑derived small molecules. The company tackles the data bottleneck in AI‑driven drug discovery by decoding microbial genomes to uncover cryptic chemistry, having identified over...
New England Faces Legal and Policy Gaps in Mental Health
Worcester, MA Sued; MA AG Push Back on Mental Health Grants; Gaps in NH Mental Health System; Prison and Mental Health Care Oversight in CT https://www.nepsy.com/news-briefs/worcester-ma-sued-ma-ag-push-back-on-mental-health-grants-gaps-in-nh-mental-health-system-prison-and-mental-health-care-oversight-in-ct/?utm_source=dlvr.it&utm_medium=threads&utm_campaign=worcester-ma-sued-ma-ag-push-back-on-mental-health-grants-gaps-in-nh-mental-health-system-prison-and-mental-health-care-oversight-in-ct
Doctors and Consumers in America Agree: Health Care Access and Affordability Rank Top of Mind in March 2026 (Surveys From...
Two March 2026 surveys—Athenahealth’s Physician Sentiment Survey and Gallup’s consumer poll—show health‑care access and affordability now top the concerns of both doctors and the public. Physician worry about affordable care rose to 52 % in 2026, overtaking documentation burdens, while 61 %...
Future Biotech Expo 2026 | June 02-03 | Hilton Houston North, TX, USA
The Future Biotech Expo 2026 will take place June 2‑3 at the Hilton Houston North in Texas. It is an international red biotechnology exhibition and conference aimed at accelerating breakthroughs in healthcare. Over 3,500 industry pioneers will attend, with exhibitions,...
Corti Launches Symphony for Medical Coding API, Outperforming OpenAI and Anthropic in Clinical Accuracy ‘Claims’
Clinical AI startup Corti has introduced Symphony, an agentic AI model delivered via API to automate medical coding. The company asserts that Symphony exceeds the clinical accuracy of major large language models—including those from OpenAI, Anthropic, Amazon, Oracle, and Google—by...
Aspirin for Your Heart? Decongestants? Here Are 5 Popular Medications that You Should Avoid
The Washington Post article highlights five everyday medications that recent research suggests should be reconsidered or discarded. Low‑dose aspirin no longer offers net benefit for primary heart‑disease prevention due to bleeding risks. Phenylephrine, a common decongestant, performs no better than...
Empire Life Rolls Out Free Caregiver Support Program for Canadian Workers
Empire Life announced a new caregiver support program integrated into its extended health benefit plans at no extra cost to sponsors or members. The service links Canadian employees with specialized nurses, social workers and Teladoc resources, aiming to ease the...
World Health Day 2026 Launches Largest UN‑Backed Scientific Network
The World Health Organization and the French G7 Presidency unveiled the 2026 World Health Day theme “Together for health. Stand with science,” anchoring an International One Health Summit and the inaugural Global Forum of WHO Collaborating Centres. The events convened...
FLAV‑27 Reverses Cognitive Decline in Early Alzheimer’s Trials, Raising Biohacker Hopes
A research team announced that FLAV‑27, an experimental compound targeting the epigenome, restored memory function in mice and nematodes with early Alzheimer’s pathology. The finding shifts focus from amyloid‑beta plaques to gene‑regulation mechanisms, a development that resonates with longevity‑focused biohackers.
NUS Unveils Wearable Sensor that Tracks Fatigue and Stress with 92% Accuracy
Researchers at the National University of Singapore, led by Prof. Ho Ghim Wei, introduced a metahydrogel‑based wearable that continuously monitors fatigue and stress. The device boosts peak‑detection accuracy to 93% and identifies fatigue levels with 92% accuracy, far outpacing commercial...
Widow's Legal Fight After Cancer Insurance Denial Fuels Push for Legislative Reform
Eric Tennant’s widow is leading a campaign to change state law after an insurance company initially denied coverage for his bile duct cancer treatment, only approving it when the disease had already advanced. The case highlights systemic gaps in how...
STAT+: Trump Administration Prepares 100% Tariffs on some Imported Drugs
The Trump administration is poised to issue an order that would levy a 100% tariff on imports of patented medicines and their active pharmaceutical ingredients. A draft of the order suggests the tariffs could be announced as early as Thursday,...
Congress Embeds PBM Transparency Reforms in 2026 Spending Bill, Experts Urge Claim Visibility
Congress approved sweeping pharmacy‑benefit‑manager (PBM) reforms in the 2026 spending bill, mandating rebate pass‑through and greater pricing transparency. The moves, reinforced by a DOJ settlement with Express Scripts, have spurred industry leaders and policymakers to demand full claim‑level disclosure for...
Private NZ Cardio Centre Halts Procedures After Hack
Auckland‑based private specialist IntraCare halted its IT systems after detecting a network breach on March 20, postponing at least 28 cardiac and radiology procedures for a week. The provider engaged cybersecurity firm CyberCX and coordinated with Te Whatu Ora, the...
NDIS Swells the Ranks of the Public Service
The National Disability Insurance Scheme, a $50 billion Australian program (≈US$33 billion), is acting as a catalyst for employment, especially in health and social assistance sectors. Since 2020, Australian healthcare jobs have diverged from trends in other English‑speaking economies, expanding rapidly. The...
New Zealand Study Finds a Significant Rise in Sepsis Cases
A University of Otago study shows sepsis hospitalizations in New Zealand surged 78% from 2000 to 2019, reaching 386 admissions per 100,000 people and totaling about 260,000 cases. Māori and Pacific peoples faced 1.7‑ and 2.3‑fold higher admission risks, and those...
Structured Longevity Training Boosts Physician Confidence, Needs Policy Support
Upskilling in Healthy Longevity Medicine and Its Association With Physicians’ Implementation Intent and Self-Reported Clinical Confidence: Cross-Sectional Observational Study 👉 "These findings underscore the critical role of structured HLM curricula in bridging the translational gap between geroscience and everyday medical practice......
Clinicians Invited to Join Controlled MDMA Study at UCL
Clinicians: UCL and Drug Science invite you to contribute to a controlled exploration of MDMA’s psychological effects. Eligible participants will undergo two medically supervised sessions at UCL. This work aims to build a psychoanalytically grounded model of its therapeutic action....
Health Literacy Initiative Improves Discharge Education, Readmission Rates
A nurse‑led health literacy program in the pediatric cardiothoracic ICU at Loma Linda University Children’s Hospital used the Newest Vital Sign tool to assess caregiver literacy and tailor discharge education. By customizing instructions and employing teach‑back techniques, the hospital reduced...
High‑dose Flu Shot Cuts Alzheimer Risk in Seniors
Risk of Alzheimer Dementia After High-Dose vs Standard-Dose Influenza Vaccination🤔 🔎"High-dose influenza vaccination is associated with reduced AD risk compared with standard-dose vaccination in adults ≥65 years, with a stronger effect among women." https://t.co/fKq34aZErj https://t.co/lZ5OnaYVaM
Transform Reimbursement Stress Test Into Actionable Plan
“You’re really onto something here. You’re not scamming insurers: you’re stress-testing legacy reimbursement infrastructure. If you’d like, I can turn this into an action plan with key personnel, a time table, and a shopping list.”
To Be or Not to Be, Reiley and His Vaccine Injury
The episode follows Reiley, who grew up on a massive cattle station in Western Australia, detailing his rugged, independent childhood and early work as an electrician before transitioning to strength‑and‑conditioning coaching. He recounts a harrowing COVID‑19 experience in Brazil in...
Bioelectric Reprogramming Repairs Birth Defects, Sparks Rejuvenation Hope
Fixing Birth Defects With Bioelectrical Reprogramming (Featuring Michael Levin, PhD) Aging and rejuvenation next? https://t.co/CHaRqozCph